These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18344550)

  • 21. HIV-1 drug resistance surveillance using dried whole blood spots.
    Bertagnolio S; Soto-Ramirez L; Pilon R; Rodriguez R; Viveros M; Fuentes L; Harrigan PR; Mo T; Sutherland D; Sandstrom P
    Antivir Ther; 2007; 12(1):107-13. PubMed ID: 17503754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests.
    Garrido C; Zahonero N; Corral A; Arredondo M; Soriano V; de Mendoza C
    J Clin Microbiol; 2009 Apr; 47(4):1031-6. PubMed ID: 19193847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher specificity of nucleic acid sequence-based amplification isothermal technology than of real-time PCR for quantification of HIV-1 RNA on dried blood spots.
    Mercier-Delarue S; Vray M; Plantier JC; Maillard T; Adjout Z; de Olivera F; Schnepf N; Maylin S; Simon F; Delaugerre C
    J Clin Microbiol; 2014 Jan; 52(1):52-6. PubMed ID: 24131691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.
    Zhou Z; Wagar N; DeVos JR; Rottinghaus E; Diallo K; Nguyen DB; Bassey O; Ugbena R; Wadonda-Kabondo N; McConnell MS; Zulu I; Chilima B; Nkengasong J; Yang C
    PLoS One; 2011; 6(11):e28184. PubMed ID: 22132237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of dried blood spots for HIV-1 drug resistance analysis.
    Hearps AC; Ryan CE; Morris LM; Plate MM; Greengrass V; Crowe SM
    Curr HIV Res; 2010 Mar; 8(2):134-40. PubMed ID: 20163343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of HIV-1 RNA measurements obtained by using plasma and dried blood spots in the automated abbott real-time viral load assay.
    Arredondo M; Garrido C; Parkin N; Zahonero N; Bertagnolio S; Soriano V; de Mendoza C
    J Clin Microbiol; 2012 Mar; 50(3):569-72. PubMed ID: 22170904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of HIV-RNA from dried blood spots using the Siemens VERSANT® HIV-1 RNA (kPCR) assay.
    Pirillo MF; Recordon-Pinson P; Andreotti M; Mancini MG; Amici R; Giuliano M
    J Antimicrob Chemother; 2011 Dec; 66(12):2823-6. PubMed ID: 21930572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso.
    Viljoen J; Gampini S; Danaviah S; Valéa D; Pillay S; Kania D; Méda N; Newell ML; Van de Perre P; Rouet F;
    J Acquir Immune Defic Syndr; 2010 Nov; 55(3):290-8. PubMed ID: 20700058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of dried blood spot specimens for HIV-1 drug resistance genotyping in young children initiating antiretroviral therapy.
    Salimo AT; Ledwaba J; Coovadia A; Abrams EJ; Technau KG; Kuhn L; Morris L; Hunt GM
    J Virol Methods; 2015 Oct; 223():30-2. PubMed ID: 26192603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of blood collection filter papers for HIV-1 DNA PCR.
    Masciotra S; Khamadi S; Bilé E; Puren A; Fonjungo P; Nguyen S; Girma M; Downing R; Ramos A; Subbarao S; Ellenberger D
    J Clin Virol; 2012 Oct; 55(2):101-6. PubMed ID: 22776163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance Genotyping.
    Aitken SC; Wallis CL; Stevens W; de Wit TR; Schuurman R
    PLoS One; 2015; 10(7):e0131541. PubMed ID: 26147689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country.
    Inzaule S; Yang C; Kasembeli A; Nafisa L; Okonji J; Oyaro B; Lando R; Mills LA; Laserson K; Thomas T; Nkengasong J; Zeh C
    J Clin Microbiol; 2013 Feb; 51(2):529-39. PubMed ID: 23224100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol.
    Bronze M; Aitken SC; Wallis CL; Steegen K; Stuyver LJ; de Wit TF; Stevens W
    J Virol Methods; 2013 Dec; 194(1-2):300-7. PubMed ID: 23994150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dried blood spots versus plasma for the quantitation of HIV-1 RNA using a real-Time PCR, m2000rt assay.
    Vidya M; Saravanan S; Rifkin S; Solomon SS; Waldrop G; Mayer KH; Solomon S; Balakrishnan P
    J Virol Methods; 2012 May; 181(2):177-81. PubMed ID: 22401801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel RealTime HIV-1 Qualitative assay for the detection of HIV-1 nucleic acids in dried blood spots and plasma.
    Huang S; Erickson B; Mak WB; Salituro J; Abravaya K
    J Virol Methods; 2011 Dec; 178(1-2):216-24. PubMed ID: 21968095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.
    Wallis CL; Papathanasopoulos MA; Lakhi S; Karita E; Kamali A; Kaleebu P; Sanders E; Anzala O; Bekker LG; Stevens G; de Wit TF; Stevens W
    J Virol Methods; 2010 Feb; 163(2):505-8. PubMed ID: 19917318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring human immunodeficiency virus type 1 RNA loads in dried blood spot specimens using NucliSENS EasyQ HIV-1 v2.0.
    van Deursen P; Oosterlaken T; Andre P; Verhoeven A; Bertens L; Trabaud MA; Ligeon V; de Jong J
    J Clin Virol; 2010 Feb; 47(2):120-5. PubMed ID: 20018560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.
    Kantor R; DeLong A; Balamane M; Schreier L; Lloyd RM; Injera W; Kamle L; Mambo F; Muyonga S; Katzenstein D; Hogan J; Buziba N; Diero L
    J Int AIDS Soc; 2014; 17(1):19262. PubMed ID: 25413893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robust and sensitive subtype-generic HIV-1 pol genotyping for use with dried serum spots in epidemiological studies.
    Hauser A; Meixenberger K; Machnowska P; Fiedler S; Hanke K; Hofmann A; Bartmeyer B; Bremer V; Bannert N; Kuecherer C
    J Virol Methods; 2018 Sep; 259():32-38. PubMed ID: 29859195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early infant human immunodeficiency virus type 1 detection suitable for resource-limited settings with multiple circulating subtypes by use of nested three-monoplex DNA PCR and dried blood spots.
    Zhang Q; Wang L; Jiang Y; Fang L; Pan P; Gong S; Yao J; Tang YW; Vermund SH; Jia Y
    J Clin Microbiol; 2008 Feb; 46(2):721-6. PubMed ID: 18077639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.